PB2282: HERPESVIRUSES REPLICATION DURING COVID-19 IN NON-HODGKIN’S LYMPHOMA PATIENTS.

por Sychevskaya, K., Kravchenko, S., Tikhomirov, D., Korneeva, A., Abdulpatahov, A., Abdurashidova, R., Keniaykina, A., Sarakaeva, Z., Tupoleva, T., Misyurina, A., Babaeva, F.
Publicado 2022

PB2089: ALGORITHM FOR SEVERE COVID-19 RISK STRATIFICATION DEPENDING MONOCLONAL ANTI-CD20 ANTIBODIES TREATMENT DURATION IN NON-HODGKIN LYMPHOMA PATIENTS.

por Sychevskaya, K., Kravchenko, S., Babaeva, F., Misyurina, A., Korneeva, A., Abdulpatahov, A., Abdurashidova, R., Keniaykina, A., Sarakaeva, Z., Fastova, E., Gorenkova, L., Nesterova, E., Mangasarova, Y., Bagova, M., Margolin, O., Magomedova, A.
Publicado 2022

P101: Combination of immune checkpoint inhibitors with BeGEV in the treatment of patients with relapsed and refractory classical Hodgkin’s lymphoma.

por Mangasarova, Ya.K., Moiseeva, T.N., Al-Radi, L.S., Margolin, O.V., Gorenkova, L.G., Nesterova, E.S., Bagova, M.O., Fastova, E.A., Abdurashidova, R.R., Sarakaeva, Z.T., Dorokhina, Elena, Kravchenko, S.K., Magomedova, A.U., Zvonkov, E.E.
Publicado 2022